The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
For Vertex these days, it’s all about the launches of three new products—sickle cell disease gene therapy Casgevy, the ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...
The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ ...
A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...
If the attention generated by BioSpace’s coverage of this landmark approval is any indication, Americans are hungry for ...
Vertex’s new drug Journavx (suzetrigine) has been hailed as a scientific breakthrough because it allays pain without entering the brain, minimizing the risk of addiction and dependence that can ...
Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...